In 2008, several principal component analyses (PCAs) Background. applied on 660,918 single-nucleotide polymorphisms (SNPs) from 938 individuals from 51 worldwide populations of the Human Genome Diversity Panel were published by Li PCAs were applied on subsets of et al. individuals sharing a common geographic origin and showed that in several geographic regions, genome-wide variations of SNPs grouped individuals by populations in the two first principal components. In this study, we replicated the PCAs applied on two geographic subsets, first on individuals from Europe and second on individuals from the Middle East & North Africa.
Introduction
Quartz Bio and the Stochastic Information Processing group are involved in the PRECISESADS project (http://www.precisesads. eu/), which aims at reclassifying Systemic Autoimmune Diseases (SADs), a group of chronic inflammatory conditions characterized by the presence of unspecific autoantibodies in the serum and resulting in serious clinical consequences, based on genetic and molecular biomarkers rather than clinical criteria.
In order to use genetic similarities to deliver personalized treatments to patients affected by SADs as well as other diseases, it is important to first understand the genetic structures in healthy populations.
In 2008, Li et al. 1 showed that although specific world regions have different genetic origins, all revealed population structures in principal component analyses (PCAs). Similar population structures were also observed in studies using other genome-wide variations datasets In an attempt to replicate these two figures, we performed quality control, minor allele frequency filtering, tag SNP selection 4 , and PCAs on both regional subsets of the SNP microarray data. The PCAs were then displayed on the first two principal components.
The replicated figures were found to match closely to the original figures, and therefore confirmed a successful replication.
Methods

Genotype data
The dataset consisted of two files: a zip file including the genotype data of 660,918 SNPs from 1,043 individuals with the annotations of the SNPs, and a text file composed of the annotations of 953 individuals (see Data and software availability).
The annotations of individuals were used to create two subsets of the data. The first contained 157 individuals from Europe and the second contained 163 individuals from the Middle East & North Africa.
Analysis sets
For each geographic region subset of the data, we verified that no individuals had missing value rates above 3% and excluded SNPs with missing value rates above 1%. An additive genetic model was then used to encode each A/B SNP (A/A = 0, A/B = 1, B/B = 2), which converts categorical SNP values to numerics by assuming that the effect of the A/B heterozygote and B/B homozygote are proportional to the number of B alleles. SNPs with minor allele frequency below 5% were excluded to remove rare variants, which are more prone to genotyping errors. In addition, in order to decrease the required computation time and memory usage, redundant SNPs were removed by applying TagSNP 4 (r2 > 0.8, window of 500,000 base pairs). The missing values were imputed by random sampling of each SNP. Then each SNP was centered and scaled to unit variance. All steps were performed using the SNPClust R package v1.0.0 2 .
For the Europe subset, a total of 375,164 SNPs from 157 individuals were selected for analysis. This defines our Europe analysis set.
For the Middle East & North Africa subset, a total of 412,979 SNPs from 163 samples were selected for analysis. This defines our Middle East & North Africa analysis set.
For comparison, the supporting online material of Li et al. reported that individuals with missing value rates above 2.5% and SNPs with missing value rates above 5% were excluded. Table S1 of Li et al. reports that 156 individuals from Europe and 160 from the Middle East & North Africa were used and the supporting online material reports that 642,690 SNPs were used.
Principal component analyses
PCAs were applied on the two analysis sets and displayed using the SNPClust R package v1.0.0 2 . Principal component analysis (PCA) is a dimensionality reduction method, which projects SNPs by linear combination to maximize the variance on successive axes, i.e. principal components, while constraining the axes to be orthogonal.
The supporting online material of Li et al. reports that they first computed the Identity-by-State (IBS) matrix among the 938 individuals by using PLINK (version not provided) 5 and then performed PCAs on the IBS matrix for each region separately. In this study, PCAs were applied on the analysis sets and not on IBS matrices.
Results
PCA of the Europe analysis set
The PCA of the Europe analysis set was displayed on the two first principal components (Figure 1 Therefore, the main results were replicated and can be independently reproduced by using publicly available data, source code, and computing environment.
We successfully confirmed that although the two geographic regions studied had different genetic origins, both exhibited population structures in PCAs.
Understanding the genetic structure of healthy populations will enable us to use genetic similarities to deliver personalized treatments to patients affected by SADs. Using this replication, the PRECISESADS project will be able to compare clusters of patients affected by SADs to clusters of healthy individuals, independently from their ancestry-driven genetic structure 2 .
Data and software availability
As stated in Li et al. 1 , the data sets are freely available online. Although the links that were provided are now outdated, the two data files are available from HGDP-CEPH: http://www.hagsc.org/ hgdp/files.html (download link: http://www.hagsc.org/hgdp/data/ hgdp.zip and http://www.cephb.fr/en/hgdp_panel.php#serie2; ftp link: ftp://ftp.cephb.fr/hgdp_v3/hgdp-ceph-unrelated.out).
The PCAs were computed and displayed using the previously published R package SNPClust v1.0.0 2 .
Computing environment in a Docker container is available from: https://hub.docker.com/r/thomaschln/reproducible-hgdp 
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from the HGDP, I agree that it is an excellent indication to go further with their study cases. I think these points would further our understanding and go beyond the partial re-analysis of a published data and reporting identical findings.
Would be very helpful for the readers to see for every analysis step where did the authors use exactly the same tool as Li and where do they differ? If at some point different tools were et al used, were the parameters set to be identical? How close was the pruned subset of SNPs when analysed by them and by Li ? et al.
The title and abstract reflect well the study content. The methods and results are clearly explained, the data are available and the analysis is provided in full details in a Docker container. Study motivation could be better explained and the conclusions in terms of consequences for their future study could be more detailed.
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